ArticleNPJ precision oncology2022

Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers.

Adel Alblihy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.